FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...

FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...

Becton, Dickinson and Company BDX, popularly known as BD, recently unveiled the BD FACSDiscover A8 Cell Analyzer. This advanced platform integrates breakthrough spectral flow cytometry with real-time ...

Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands ...

Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...

On behalf of the BD+C editorial team, thank you for participating in BD+C's 2026 Giants 400 Technology and Innovation Survey. This research project is part of an ongoing effort by the BD+C editorial ...